内源性和食源性抑制剂对udp -葡萄糖醛酸糖基转移酶1A9的协同和加性抑制作用。

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY Basic & Clinical Pharmacology & Toxicology Pub Date : 2024-12-25 DOI:10.1111/bcpt.14116
Ruixue Li, Ling Xiao, Wenjuan Li, Wenjing Li, Kuan Zhao, Liangliang Zhu
{"title":"内源性和食源性抑制剂对udp -葡萄糖醛酸糖基转移酶1A9的协同和加性抑制作用。","authors":"Ruixue Li,&nbsp;Ling Xiao,&nbsp;Wenjuan Li,&nbsp;Wenjing Li,&nbsp;Kuan Zhao,&nbsp;Liangliang Zhu","doi":"10.1111/bcpt.14116","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>UDP-glucuronosyltransferases (UGTs) are responsible for inactivation of a variety of drugs, endogenous hormones and environmental toxicants. Chemical inhibitors are a common factor decreasing UGT activities and furtherly inducing health problems. Although simultaneously encountering different inhibitors is readily to occur, no information is available for combined inhibition of UGT. This in vitro study investigates the combined inhibition of human UGT1A9 by endogenous and foodborne inhibitors (magnolol, di-bromophenols, UDP). <i>J</i> values (the ratio of inhibitory rate to the remaining activity) are analysed to determine the combined inhibition type. The combined inhibition of di-bromophenols and UDP obeys additive inhibition, in which combined <i>J</i> values equal to the sum of individual <i>J</i> values in alone inhibition assays. Meanwhile, there is a synergistic effect between 2,4-di-bromophenol and magnolol with combination index values ranging from 0.10 to 0.85. Further assays indicate that 2,4-di-bromophenol decreases IC<sub>50</sub> values for magnolol and vice versa. Kinetic analysis confirms that the two inhibitors and UGT1A9 can form a ternary complex with the inhibition constants of 0.0188 μM (magnolol) and 0.634 (2,4-di-bromophenol) μM. In summary, this study demonstrates that besides additive inhibition, synergistic inhibition is a probable occurrence in combined inhibition of UGT. It is suggested that the inhibitors can increase mutual inhibitory effects which deserves attentions in future UGT inhibition related studies.</p>\n </div>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"136 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Synergistic and Additive Inhibition of UDP-Glucuronosyltransferase 1A9 by Endogenous and Foodborne Inhibitors\",\"authors\":\"Ruixue Li,&nbsp;Ling Xiao,&nbsp;Wenjuan Li,&nbsp;Wenjing Li,&nbsp;Kuan Zhao,&nbsp;Liangliang Zhu\",\"doi\":\"10.1111/bcpt.14116\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>UDP-glucuronosyltransferases (UGTs) are responsible for inactivation of a variety of drugs, endogenous hormones and environmental toxicants. Chemical inhibitors are a common factor decreasing UGT activities and furtherly inducing health problems. Although simultaneously encountering different inhibitors is readily to occur, no information is available for combined inhibition of UGT. This in vitro study investigates the combined inhibition of human UGT1A9 by endogenous and foodborne inhibitors (magnolol, di-bromophenols, UDP). <i>J</i> values (the ratio of inhibitory rate to the remaining activity) are analysed to determine the combined inhibition type. The combined inhibition of di-bromophenols and UDP obeys additive inhibition, in which combined <i>J</i> values equal to the sum of individual <i>J</i> values in alone inhibition assays. Meanwhile, there is a synergistic effect between 2,4-di-bromophenol and magnolol with combination index values ranging from 0.10 to 0.85. Further assays indicate that 2,4-di-bromophenol decreases IC<sub>50</sub> values for magnolol and vice versa. Kinetic analysis confirms that the two inhibitors and UGT1A9 can form a ternary complex with the inhibition constants of 0.0188 μM (magnolol) and 0.634 (2,4-di-bromophenol) μM. In summary, this study demonstrates that besides additive inhibition, synergistic inhibition is a probable occurrence in combined inhibition of UGT. It is suggested that the inhibitors can increase mutual inhibitory effects which deserves attentions in future UGT inhibition related studies.</p>\\n </div>\",\"PeriodicalId\":8733,\"journal\":{\"name\":\"Basic & Clinical Pharmacology & Toxicology\",\"volume\":\"136 1\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-12-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic & Clinical Pharmacology & Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.14116\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.14116","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

udp -葡萄糖醛酸转移酶(UGTs)负责多种药物,内源性激素和环境毒物的失活。化学抑制剂是降低UGT活性并进一步诱发健康问题的常见因素。虽然同时遇到不同的抑制剂很容易发生,但没有关于联合抑制UGT的信息。这项体外研究考察了内源性和食源性抑制剂(厚朴酚、二溴酚、UDP)对人UGT1A9的联合抑制作用。通过分析J值(抑制率与剩余活性的比值)来确定联合抑制类型。二溴酚和UDP的联合抑制服从加性抑制,其中联合J值等于单独抑制试验中单个J值的总和。同时,2,4-二溴酚与厚朴酚之间存在协同效应,组合指数在0.10 ~ 0.85之间。进一步的分析表明2,4-二溴苯酚降低厚朴酚的IC50值,反之亦然。动力学分析证实,两种抑制剂与UGT1A9可形成三元配合物,抑制常数分别为0.0188 μM(厚朴酚)和0.634 μM(2,4-二溴苯酚)。综上所述,本研究表明在UGT联合抑制中,除了加性抑制外,协同抑制也可能发生。提示抑制剂可以增强相互抑制作用,值得今后UGT抑制相关研究的关注。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Synergistic and Additive Inhibition of UDP-Glucuronosyltransferase 1A9 by Endogenous and Foodborne Inhibitors

UDP-glucuronosyltransferases (UGTs) are responsible for inactivation of a variety of drugs, endogenous hormones and environmental toxicants. Chemical inhibitors are a common factor decreasing UGT activities and furtherly inducing health problems. Although simultaneously encountering different inhibitors is readily to occur, no information is available for combined inhibition of UGT. This in vitro study investigates the combined inhibition of human UGT1A9 by endogenous and foodborne inhibitors (magnolol, di-bromophenols, UDP). J values (the ratio of inhibitory rate to the remaining activity) are analysed to determine the combined inhibition type. The combined inhibition of di-bromophenols and UDP obeys additive inhibition, in which combined J values equal to the sum of individual J values in alone inhibition assays. Meanwhile, there is a synergistic effect between 2,4-di-bromophenol and magnolol with combination index values ranging from 0.10 to 0.85. Further assays indicate that 2,4-di-bromophenol decreases IC50 values for magnolol and vice versa. Kinetic analysis confirms that the two inhibitors and UGT1A9 can form a ternary complex with the inhibition constants of 0.0188 μM (magnolol) and 0.634 (2,4-di-bromophenol) μM. In summary, this study demonstrates that besides additive inhibition, synergistic inhibition is a probable occurrence in combined inhibition of UGT. It is suggested that the inhibitors can increase mutual inhibitory effects which deserves attentions in future UGT inhibition related studies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
6.50%
发文量
126
审稿时长
1 months
期刊介绍: Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.
期刊最新文献
Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder Fluvoxamine Inhibited NLRP3 and NF-κB Inflammatory Pathways and Maintained Genital Functions by Ameliorating CD-MPR, KISS-1, AQP4 and Claudin-1 Expressions In Vivo Investigation of the Effects of Nonylphenol on the Pituitary–Adrenal Axis and Pineal Gland in Male Rats Addressing Improper Medicine Storage Practices: Commentary on Louhisalmi et  al.'s Study Plasma NGAL, suPAR, KIM-1 and GDF-15 for Improving Glomerular Filtration Rate Estimation in Older Hospitalized Patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1